Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 2
2006 8
2007 4
2008 3
2009 3
2010 1
2011 1
2012 3
2013 2
2014 1
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Immunohistochemistry: what can go wrong?
Yaziji H, Barry T. Yaziji H, et al. Among authors: barry t. Adv Anat Pathol. 2006 Sep;13(5):238-46. doi: 10.1097/01.pap.0000213041.39070.2f. Adv Anat Pathol. 2006. PMID: 16998317 Review.
Immunohistochemistry cocktails are here to stay: Center for Medicare and Medicaid Services should revise its new reimbursement policy.
Yaziji H, Eisen R, Wick M, Badve S, Cartun R, Haas T, Marolt M, Hicks D, Martin A, Barry T, Alsabeh R, Taylor J, Fulton R, Goldsmith J, Shen S, Taylor C, Swanson P. Yaziji H, et al. Among authors: barry t. Am J Clin Pathol. 2012 Jul;138(1):10-1. doi: 10.1309/AJCPCGFDF4ECG8QN. Am J Clin Pathol. 2012. PMID: 22706851 No abstract available.
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG; Members of the Standardization Ad-Hoc Consensus Committee. Yaziji H, et al. Among authors: barry ts. Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):513-20. doi: 10.1097/PAI.0b013e31818a9d3a. Appl Immunohistochem Mol Morphol. 2008. PMID: 18931614
Immunohistochemistry cocktails are here to stay: Center of Medicare and Medicaid Services should revise its new reimbursement policy.
Yaziji H, Eisen R, Wick M, Swanson P, Badve S, Cartun R, Haas T, Marolt M, Hicks D, Martin A, Barry T, Alsabeh R, Taylor J, Fulton R, Goldsmith J, Shen S, Taylor C. Yaziji H, et al. Among authors: barry t. Appl Immunohistochem Mol Morphol. 2012 Jul;20(4):331-3. doi: 10.1097/PAI.0b013e31825ed8a5. Appl Immunohistochem Mol Morphol. 2012. PMID: 22706071 No abstract available.
Immunomodulator agent-related lymphoproliferative disorders.
Hasserjian RP, Chen S, Perkins SL, de Leval L, Kinney MC, Barry TS, Said J, Lim MS, Finn WG, Medeiros LJ, Harris NL, O'Malley DP. Hasserjian RP, et al. Among authors: barry ts. Mod Pathol. 2009 Dec;22(12):1532-40. doi: 10.1038/modpathol.2009.131. Epub 2009 Sep 18. Mod Pathol. 2009. PMID: 19767727 Free article.
Nuclear beta-catenin in mesenchymal tumors.
Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB, Nielsen TO. Ng TL, et al. Among authors: barry ts. Mod Pathol. 2005 Jan;18(1):68-74. doi: 10.1038/modpathol.3800272. Mod Pathol. 2005. PMID: 15375433 Free article.
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS).
Wärnberg F, Karlsson P, Holmberg E, Sandelin K, Whitworth PW, Savala J, Barry T, Leesman G, Linke SP, Shivers SC, Vicini F, Shah C, Weinmann S, Mann GB, Bremer T. Wärnberg F, et al. Among authors: barry t. Cancers (Basel). 2021 Dec 3;13(23):6103. doi: 10.3390/cancers13236103. Cancers (Basel). 2021. PMID: 34885211 Free PMC article.
Peripheral T-cell lymphomas expressing CD30 and CD15.
Barry TS, Jaffe ES, Sorbara L, Raffeld M, Pittaluga S. Barry TS, et al. Am J Surg Pathol. 2003 Dec;27(12):1513-22. doi: 10.1097/00000478-200312000-00003. Am J Surg Pathol. 2003. PMID: 14657710
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy.
Weinmann S, Leo MC, Francisco M, Jenkins CL, Barry T, Leesman G, Linke SP, Whitworth PW, Patel R, Pellicane J, Wärnberg F, Bremer T. Weinmann S, et al. Among authors: barry t. Clin Cancer Res. 2020 Aug 1;26(15):4054-4063. doi: 10.1158/1078-0432.CCR-19-1152. Epub 2020 Apr 27. Clin Cancer Res. 2020. PMID: 32341032
31 results